美国 · SEC FORM 4
Cryoport, Inc.
CYRX · Nasdaq · CIK 0001124524 · Healthcare · Integrated Freight & Logistics
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
12 同一窗口内观察到的 Form 4 交易行
5 sales · 7 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,362,636
- 上期报告
- 2,786,514
- 日均成交量
- 698,414
- 回补天数
- 3.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
27 transaction lines in the latest 365-day window; 317 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | SHELTON JERRELL | 卖出 (S) | Common Stock | 28,800 | USD 14.91 | USD 429,408 | SEC 申报 ↗ |
| 2026-06-11 | ZECCHINI EDWARD J | 卖出 (S) | Common Stock | 33,600 | USD 14.47 | USD 486,192 | SEC 申报 ↗ |
| 2026-06-11 | ZECCHINI EDWARD J | 期权行权／转换 (M) | Common Stock | 33,600 | USD 4.80 | USD 161,280 | SEC 申报 ↗ |
展开近期 Form 4 证据 (27 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | SHELTON JERRELL | 卖出 (S) | Common Stock | 28,800 | USD 14.91 | USD 429,408 | SEC 申报 ↗ |
| 2026-06-11 | ZECCHINI EDWARD J | 卖出 (S) | Common Stock | 33,600 | USD 14.47 | USD 486,192 | SEC 申报 ↗ |
| 2026-06-11 | ZECCHINI EDWARD J | 期权行权／转换 (M) | Common Stock | 33,600 | USD 4.80 | USD 161,280 | SEC 申报 ↗ |
| 2026-06-10 | ZECCHINI EDWARD J | 卖出 (S) | Common Stock | 1,400 | USD 15.23 | USD 21,322 | SEC 申报 ↗ |
| 2026-06-10 | ZECCHINI EDWARD J | 期权行权／转换 (M) | Common Stock | 1,400 | USD 4.80 | USD 6,720 | SEC 申报 ↗ |
| 2026-06-08 | Mandalam Ramkumar | 卖出 (S) | Common Stock | 23,214 | USD 15.44 | USD 358,424 | SEC 申报 ↗ |
| 2026-06-05 | BADDOUR LINDA | 奖励／授予 (A) | Common Stock | 10,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Mandalam Ramkumar | 奖励／授予 (A) | Common Stock | 10,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Hariri Robert J | 奖励／授予 (A) | Common Stock | 10,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | HANCOCK DANIEL M | 奖励／授予 (A) | Common Stock | 10,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | STEFANOVICH ROBERT | 卖出 (S) | Common Stock | 169,427 | USD 16.27 | USD 2,756,577 | SEC 申报 ↗ |
| 2026-04-21 | SHELTON JERRELL | 期权行权／转换 (M) | Common Stock | 104,007 | USD 1.87 | USD 194,493 | SEC 申报 ↗ |
| 2026-04-06 | SHELTON JERRELL | 期权行权／转换 (M) | Common Stock | 50,000 | USD 1.87 | USD 93,500 | SEC 申报 ↗ |
| 2026-03-23 | Sawicki Mark W | 卖出 (S) | Common Stock | 1,341 | USD 8.18 | USD 10,969 | SEC 申报 ↗ |
| 2026-03-23 | STEFANOVICH ROBERT | 卖出 (S) | Common Stock | 1,094 | USD 8.18 | USD 8,949 | SEC 申报 ↗ |
| 2026-03-23 | SHELTON JERRELL | 卖出 (S) | Common Stock | 2,894 | USD 8.18 | USD 23,673 | SEC 申报 ↗ |
| 2026-03-23 | SHELTON JERRELL | 期权行权／转换 (M) | Common Stock | 25,000 | USD 1.87 | USD 46,750 | SEC 申报 ↗ |
| 2026-03-16 | ZECCHINI EDWARD J | 卖出 (S) | Common Stock | 2,014 | USD 8.00 | USD 16,112 | SEC 申报 ↗ |
| 2026-03-16 | Sawicki Mark W | 卖出 (S) | Common Stock | 3,235 | USD 8.00 | USD 25,880 | SEC 申报 ↗ |
| 2026-03-16 | SHELTON JERRELL | 卖出 (S) | Common Stock | 7,918 | USD 8.00 | USD 63,344 | SEC 申报 ↗ |
| 2026-03-16 | STEFANOVICH ROBERT | 卖出 (S) | Common Stock | 2,743 | USD 8.00 | USD 21,944 | SEC 申报 ↗ |
| 2026-03-14 | ZECCHINI EDWARD J | 奖励／授予 (A) | Common Stock | 21,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-14 | Sawicki Mark W | 奖励／授予 (A) | Common Stock | 22,845 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-14 | STEFANOVICH ROBERT | 奖励／授予 (A) | Common Stock | 27,413 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | STEFANOVICH ROBERT | 卖出 (S) | Common Stock | 38,700 | USD 7.76 | USD 300,312 | SEC 申报 ↗ |
| 2026-03-12 | STEFANOVICH ROBERT | 期权行权／转换 (M) | Common Stock | 87,188 | USD 1.87 | USD 163,042 | SEC 申报 ↗ |
| 2025-12-10 | Mandalam Ramkumar | 卖出 (S) | Common Stock | 11,570 | USD 9.99 | USD 115,584 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CYRX |
| CIK | 0001124524 |
| 行业 | Healthcare |
| 细分行业 | Integrated Freight & Logistics Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 317 transaction lines from 2020-02-05 to 2026-08-11 0 P purchase lines · 147 S sale lines · 170 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.